These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 18558198

  • 1. Safety of minimal immunosuppression in liver transplantation for hepatoblastoma.
    Suh MY, Wang K, Gutweiler JR, Misra MV, Krawczuk LE, Jenkins RL, Lillehei CW, Jonas MM, Kim HB.
    J Pediatr Surg; 2008 Jun; 43(6):1148-52. PubMed ID: 18558198
    [Abstract] [Full Text] [Related]

  • 2. Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database.
    Austin MT, Leys CM, Feurer ID, Lovvorn HN, O'Neill JA, Pinson CW, Pietsch JB.
    J Pediatr Surg; 2006 Jan; 41(1):182-6. PubMed ID: 16410130
    [Abstract] [Full Text] [Related]

  • 3. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
    Ailawadi G, Smith PW, Oka T, Wang H, Kozower BD, Daniel TM, Kron IL, Jones DR.
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
    [Abstract] [Full Text] [Related]

  • 4. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M, Sher D, Grant D, Deluca E, Alonso E, Whitington PF, Superina RA.
    J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
    [Abstract] [Full Text] [Related]

  • 5. Liver transplantation for malignant tumours in children.
    Avila LF, Luis AL, Hernandez F, Garcia Miguel P, Jara P, Andres AM, Lopez Santamaría M, Tovar JA.
    Eur J Pediatr Surg; 2006 Dec; 16(6):411-4. PubMed ID: 17211789
    [Abstract] [Full Text] [Related]

  • 6. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ, Mazariegos GV, Sindhi R, Abu-Elmagd KM, Reyes J.
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [Abstract] [Full Text] [Related]

  • 7. Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study.
    Boillot O, Mayer DA, Boudjema K, Salizzoni M, Gridelli B, Filipponi F, Trunecka P, Krawczyk M, Clavien PA, Ducerf C, Margarit C, Margreiter R, Pallardo JM, Hoeckerstedt K, Pageaux GP.
    Liver Transpl; 2005 Jan; 11(1):61-7. PubMed ID: 15690537
    [Abstract] [Full Text] [Related]

  • 8. Treatment with immunoglobulin improves outcome for pediatric liver transplant recipients.
    Bucuvalas JC, Anand R, Studies of Pediatric Liver Transplantation Research Group.
    Liver Transpl; 2009 Nov; 15(11):1564-9. PubMed ID: 19877216
    [Abstract] [Full Text] [Related]

  • 9. Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile.
    Jain A, Marcos A, Reyes J, Mazariagos G, Kashyap R, Eghtesad B, Marsh W, Fontas P, De Vera M, Costa G, Patel K, Gadomski M, Starzl T, Fung J.
    Transplant Proc; 2005 Mar; 37(2):1207-10. PubMed ID: 15848671
    [Abstract] [Full Text] [Related]

  • 10. Outcome of induction immunosuppression for liver transplantation comparing anti-thymocyte globulin, daclizumab, and corticosteroid.
    Uemura T, Schaefer E, Hollenbeak CS, Khan A, Kadry Z.
    Transpl Int; 2011 Jul; 24(7):640-50. PubMed ID: 21429047
    [Abstract] [Full Text] [Related]

  • 11. Studies of Pediatric Liver Transplantation 2002: patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada.
    Martin SR, Atkison P, Anand R, Lindblad AS, SPLIT Research Group.
    Pediatr Transplant; 2004 Jun; 8(3):273-83. PubMed ID: 15176966
    [Abstract] [Full Text] [Related]

  • 12. Pediatric liver transplantation with daclizumab induction.
    Heffron TG, Pillen T, Smallwood GA, Welch D, Oakley B, Romero R.
    Transplantation; 2003 Jun 27; 75(12):2040-3. PubMed ID: 12829908
    [Abstract] [Full Text] [Related]

  • 13. High survival rates after liver transplantation for hepatoblastoma and hepatocellular carcinoma.
    Kosola S, Lauronen J, Sairanen H, Heikinheimo M, Jalanko H, Pakarinen M.
    Pediatr Transplant; 2010 Aug 27; 14(5):646-50. PubMed ID: 20345611
    [Abstract] [Full Text] [Related]

  • 14. Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma: new trends and future opportunities.
    Cruz RJ, Ranganathan S, Mazariegos G, Soltys K, Nayyar N, Sun Q, Bond G, Shaw PH, Haberman K, Krishnamurti L, Marsh JW, Humar A, Sindhi R.
    Surgery; 2013 Feb 27; 153(2):150-9. PubMed ID: 23331862
    [Abstract] [Full Text] [Related]

  • 15. [Liver transplatation for malignant tumors in children].
    Avila LF, Encinas JL, Leal N, Guinea A, García Miguel P, Jara P, Murcia J, Gamez M, Guinea A, López Santamaría M, Tovar JA.
    Cir Pediatr; 2007 Oct 27; 20(4):189-93. PubMed ID: 18351237
    [Abstract] [Full Text] [Related]

  • 16. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival.
    Jacob DA, Neumann UP, Bahra M, Langrehr JM, Neuhaus P.
    Transplant Proc; 2005 May 27; 37(4):1691-2. PubMed ID: 15919432
    [Abstract] [Full Text] [Related]

  • 17. Outcomes of primary liver cancer in children: an appraisal of experience.
    Pham TH, Iqbal CW, Grams JM, Zarroug AE, Wall JC, Ishitani MB, Nagorney DM, Moir C.
    J Pediatr Surg; 2007 May 27; 42(5):834-9. PubMed ID: 17502194
    [Abstract] [Full Text] [Related]

  • 18. Long-term survival and late graft loss in pediatric liver transplant recipients--a 15-year single-center experience.
    Wallot MA, Mathot M, Janssen M, Hölter T, Paul K, Buts JP, Reding R, Otte JB, Sokal EM.
    Liver Transpl; 2002 Jul 27; 8(7):615-22. PubMed ID: 12089716
    [Abstract] [Full Text] [Related]

  • 19. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.
    Jacob DA, Neumann UP, Bahra M, Klupp J, Puhl G, Neuhaus R, Langrehr JM.
    Clin Transplant; 2006 Jul 27; 20(2):211-20. PubMed ID: 16640529
    [Abstract] [Full Text] [Related]

  • 20. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
    Assy N, Adams PC, Myers P, Simon V, Minuk GY, Wall W, Ghent CN.
    Transplantation; 2007 Jun 27; 83(12):1571-6. PubMed ID: 17589339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.